Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Session Type:

Availability:

Showing session: reset

Wednesday Press Conference

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2
Wednesday Press Conference
Discussion of Oral Abstract Session 10 – Getting to 90-90-90 and Symposium Session 5 – Reaching 90-90-90 and Beyond: Challenges and Innovations
Chair
Diane Havlir
University of California, San Francisco, CA, United States
OA10: Botswana Is Close to Meeting UNAIDS 2020 Goals of 90-90-90 Coverage
Tendani Gaolathe
Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana
OA10: Streamlining Antiretroviral Therapy Uptake: A Stepped-Wedge Cluster Randomized Trial
Gideon Amanyire
Makerere University College of Health Sciences, Kampala, Uganda
OA10: HIV Mortality by Care Cascade Stage and Implications for Universal ART Eligibility
Jeffrey Eaton
Imperial College London, London, United Kingdom
SS5: Missing But in Action: Where Are the Men?
Helen Ayles
London School of Hygiene & Tropical Medicine, London, United Kingdom
SS5: Innovations in Antiretroviral Therapy Delivery
Anna Grimsrud
International AIDS Society, Cape Town, South Africa
video audio mp3
from CROI 2016 on February 24, 2016 12:30 PM-1:30 PM
Wednesday Press Conference
Discussion of Oral Abstract Session 9 – Expanding the Toolbox for Prevention and Themed Discussion Session 12 – It's Complicated: Renal Function and STIs in PrEP Users and Poster Abstract Session 3 – Predictors of PrEP Coverage and Uptake
Chair
Sharon L. Hillier
University of Pittsburgh School of Medicine, Magee-Womens Hospital, PA, United States
OA9: ÉCLAIR: Phase 2A Safety and PK Study of Cabotegravir LA in HIV Uninfected Men
Martin Markowitz
Aaron Diamond AIDS Research Center, New York, NY, United States
TD12: Higher Cumulative TFV/FTC Levels in PrEP Associated With Decline in Renal Function
Monica Gandhi
University of California San Francisco, San Francisco, CA, United States
TD12: Changes in Renal Function Associated With TDF/FTC PrEP Use in the US Demo Project
Albert Y. Liu
San Francisco Dept of Public Health, San Francisco, CA, United States
TD12: STI Data From Community-Based PrEP Implementation Suggest Changes to CDC Guidelines
Sarit A. Golub
Hunter College, City University of New York, NY, United States
PAS3: HPTN 073: PrEP Uptake and Use by Black Men Who Have Sex With Men in 3 US Cities
Darrell P. Wheeler
State University of New York at Albany, Albany, NY, United States
video audio mp3
from CROI 2016 on February 24, 2016 12:30 PM-1:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2